The Importance of Medical Guidance Prescription weight loss medications are most effective when guided by experienced medical professionals
From there, our team will work with you to establish when you should increase your dosage based on any side effects you may be experiencing, or if the medication still works properly for you
Promotes digestive health and gutbrain axis support
The structural properties of GLP-1 agonists suggest they undergo hepatic metabolism and may not concentrate in milk, but absence of evidence is not evidence of safety in vulnerable infant populations
The appropriate level of care depends on symptom severity, but serious or rapidly worsening symptoms should not be managed by simply waiting for them to pass
There are three GLP-1 FDA decisions expected in early-mid 2026 Eli Lillys Mounjaro with a new indication to reduce the risk of major adverse cardiovascular events (MACE) in patients with T2DM Eli Lillys oral once-daily orforglipron for weight loss Novo Nordisks higher dose (7.2 mg) injectable once-weekly Wegovy for weight loss Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape